[Assessment of Merlin Assay for diagnosis of malignant melanoma]
Record ID 32018013576
Danish
Original Title:
Merlin Assay
Authors' objectives:
The Merlin Assay is a non-invasive gene expression profiling test (GEP) for the diagnosis of malignant melanomas. The assay analyzes melanoma tumor tissue to determine a patient’s risk of developing lymph node metastases. The test is based on a CP-GEP algorithm, which combines clinical and pathological parameters with the gene expression of eight genes to assess individual risk, providing a low- or high-risk outcome.
Details
Project Status:
Ongoing
URL for project:
https://behandlingsraadet.dk/find-evalueringer-analyser/evalueringer/2024/merlin-assay
Anticipated Publish Date:
2025
English language abstract:
There is no English language summary available
Publication Type:
Not Assigned
Country:
Denmark
MeSH Terms
- Skin Neoplasms
- Melanoma
- Gene Expression Profiling
- Sentinel Lymph Node Biopsy
Contact
Organisation Name:
The Danish Health Technology Council
Contact Address:
Niels Jernes Vej 6a, 9220 Aalborg
Contact Name:
Nikolaj Hellmuth Skak
Contact Email:
nsp@behandlingsraadet.dk
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.